write an article on the business model for charles schwab corporation and comparison of celltech and ppl therapeutics
Hi, I am looking for someone to write an article on the business model for charles schwab corporation and comparison of celltech and ppl therapeutics Paper must be at least 1250 words. Please, no plagiarized work! The first group comprising of 12 million investors want to pass on investment decision burden on others. The next group consisting of 3 million investors are able to take their own investment decisions. The leftover 15 million investors need proper advice and education for investment propose.
The primary requirement of the customers of Schwab is price and the corresponding security of their invested money. Trust is the most important component that builds customers’ confidence, which can be achieved by providing quality services. Therefore, the customers want a lower price from Schwab for the services, information, and advice it provides regarding the investment.
The business model for Charles Schwab Corporation is based on the transaction. The core operation area of the company is to provide services to investors. The services provided by Schwab can be termed as financial services for investment purposes. Specifically, it provides financial services related to security brokerage. In order to develop a conventional business model, it has introduced several innovative technologies in a service model to cater to its customers. This has lead to significant growth of the company. For convenient services, it has developed ‘telebroker’, ‘Schwablink’, ‘eSchwab’ and ‘one source’.
Schwab generates its revenue from the brokerage commission paid by its client for investment transitions. With the help of its conventional business model, it has been able to offer services like brokerages at a lower commission. In 1991, it became famous as a low-cost broker. It made forward integration by purchasing Mayer and Schweitzer which helped the company to reduce bid-ask spreads. The company earns around 50% of its revenue from its commissions, 13% from principle transaction and rest from mutual fund services and interest revenue. .  .
